Gilead Sciences on Tuesday reported that its fourth-quarter net income fell 22 percent to $629.4 million, compared to the same period last year. For the quarter, revenue dropped 1.7 percent to $2 billion, just slightly ahead of the $1.9 billion forecast by analysts.
Reference Articles
Gilead has lower qtrly profit, setback at FDA - (EDITORS)
Gilead Sciences announces fourth quarter and full year 2010 financial results - (Gilead Sciences)
Gilead Q4 profit dips, NDA turned down - (San Jose Business Journal)
Gilead Sciences Q4 profit declines, yet tops estimate - (Stock Markets Review)
**Published in "First Word"
No comments:
Post a Comment